ENT Devices Market size to exceed $36bn by 2030

ENT Devices Market size is set to surpass USD 36 billion by 2030, according to a new research report by Global Market Insights Inc.
 

Surging prevalence of hearing impairment among geriatric population coupled with developing healthcare infrastructure will favor the market growth. Moreover, favorable regulatory environment for ENT devices in developed nations countries and growing funding by government to support healthcare research and manufacturing.

For instance, BEIS and DHSC committed to invest £200 million to support NHS-led health research into diagnostics and treatment through new privacy-preserving platforms and clinical research services. Therefore, favorable government decisions and increased healthcare spending increased the demand for healthcare services.
 

Surging demand for minimally invasive ENT procedures globally will boost market progression

Minimally invasive surgeries are witnessing a steady preference, as it offers shorter recovery periods and cosmetic appeal. This preference fuels demand for ENT endoscopic and bronchoscopy devices in a variety of healthcare settings, resulting in market expansion. Moreover, in the last few years, minimally invasive ENT treatments such as laryngeal surgery, trans-oral robotic surgery, septoplasty, tonsillectomy, and endoscopic sinus surgery have been performed.
 

For instance, The XprESS ENT dilation system by Stryker enables minimally invasive treatment of patients suffering from eustachian tube dysfunction and chronic sinusitis. As it offers less operative bleeding and faster recovery time compared to traditional methods of surgery. The patented balloon dilation technology easily incorporates balloon dilation into preferred site of care, i.e., operating room or ambulatory setting. Advanced tools linked with robotics have revolutionized the treatment of cancers of the ear, nose, and throat.
 

Growing demand for nasal splints will help the market expansion

ENT devices market from nasal splint segment held 8.9% business share in 2021 and is set to register a significant CAGR through 2030. The demand for nasal splints has increased owing to its excessive demand in rhinoplasty surgeries. The nasal splints are placed on the nose after rhinoplasty surgery. The external splint serves numerous purposes, including maintaining the altered form of the nose. The splint is also used to keep the nose straight after it has been reshaped.
 

Browse key industry insights spread across 170 pages with 229 market data tables & 10 figures & charts from the report, “Ear-Nose-Throat (ENT) Devices Market Analysis By Product Type (Diagnostic Ear, Nose, And Throat (ENT) Devices [Rigid Endoscopes {Rhinoscopes, Laryngoscopes, Otological Endoscopes}, Flexible Endoscopes, Robot Assisted Endoscope, Hearing Screening Device], Surgical Ear, Nose, And Throat (ENT) Devices [Radiofrequency Handpieces, Powered Surgical Instrument, Otological Drill Burrs, ENT Hand Instruments, Tympanostomy Tubes, Sinus Dilation Devices, Nasal Packing Devices], Hearing Aids {In-The-Ear (ITE), Receiver ITE, Behind-The-Ear, Canal Hearing Aids ITC, CIC, IIC}, Hearing Implants {Auditory Brainstem Implants, Cochlear Implants, Middle Ear Implants, Bone Anchored Hearing System}, Voice Prosthesis Devices, Nasal Splints {Internal Nasal Splints,  External Nasal Splints}), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/ent-devices-market
 

Presence of skilled surgeons in hospitals will fuel the market expansion

ENT devices market from hospital segment garnered more than 35% business share in 2021. The segment is expected to grow substantially over the forthcoming years owing to high number of diagnostic and surgical procedures performed in hospitals. Also, having advanced ENT devices on board aids in achieving absolute precision during diagnosis or surgery. Besides from that, to reduce the risk of error, the most difficult and sensitive diagnostic procedures are performed in hospitals by skilled surgeons. Furthermore, as the healthcare business has grown at a rapid pace, the number of hospitals is projected to increase as well and equipped with ENT devices.
 

Rising awareness and high adoption rate of implants in Europe will augment the market revenue

Europe ENT devices market exceeded USD 5.7 billion in 2021. This is due to the rising awareness and high adoption rate of ENT devices such as hearing implants. For instance, according to the National Institute for Health and Care Excellence, approximately 1,260 people in England receive cochlear implants each year. Additionally, several government initiatives, and product approvals will promote the regional market statistics.
 

For instance, in May 2021, Intersect ENT Inc. a global ear, nose and throat medical technology announced that its PROPEL Contour (mometasone furoate) sinus implant got approved with CE Mark. This approval enabled its distribution and sales in the European Union. Furthermore, present of prominent market players operating in ENT devices in the region will foster the European industry growth.
 

Major leaders are inclining on ENT devices and are focusing on developing new products

Some of the prominent players functioning in the ENT devices market include, Accelerant (Johnson & Johnson), Atos Medical, Boston Scientific, Cochlear Limited, Demant (Oticon), Lumenis Be Ltd, Medtronic, Meril Life Sciences Pvt. Ltd, Narang Medical Limited, PENTAX Medical, Signia, Smith & Nephew, Sonova Group, Starkey, Stryker, Surgiform Innovative Surgical Products, and Welch Allyn. These key industry players are involved in several growth strategies with continued innovations and technology improvements to sustain market competition in corneal implants business.
 

For instance, in May 2021, Hillrom announced the launch of the new the Welch Allyn MacroView Plus Otoscope and Welch Allyn PanOptic Plus Ophthalmoscope. Such innovative launches by the company help in widening its product portfolio in market.